# HFS-guided Renal Ablation for Improving Outcome of Renal Denervation Procedure

Study · id `cardio:ct-nct02608632` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02608632](<https://clinicaltrials.gov/study/NCT02608632>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02608632

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 170 participants.

## Technical summary

Registry record NCT02608632. Randomized; double masking; primary purpose treatment. Start 2013-02 (registry gives no type); primary completion 2015-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 170 participants (planned count; ClinicalTrials.gov record NCT02608632, source copy `cardio:ctgov-nct02608632-2015-11-20`, retrieved 2026-10-26)
- Start date: 2013-02 (registry gives no type) (ClinicalTrials.gov record NCT02608632, source copy `cardio:ctgov-nct02608632-2015-11-20`, retrieved 2026-10-26)
- Primary completion: 2015-12 (anticipated) (ClinicalTrials.gov record NCT02608632, source copy `cardio:ctgov-nct02608632-2015-11-20`, retrieved 2026-10-26)
- Completion: 2016-02 (anticipated) (ClinicalTrials.gov record NCT02608632, source copy `cardio:ctgov-nct02608632-2015-11-20`, retrieved 2026-10-26)
- Countries: Russia (ClinicalTrials.gov record NCT02608632, source copy `cardio:ctgov-nct02608632-2015-11-20`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02608632-2015-11-20`, retrieved 2026-10-26)

## The registry's words

- Brief title: HFS-guided Renal Ablation for Improving Outcome of Renal Denervation Procedure
- Condition: Hypertension
- Intervention (Device): Renal denervation guided by HFS
- Intervention (Device): Renal denervation as standard procedure
- Lead sponsor: Meshalkin Research Institute of Pathology of Circulation
- Lead sponsor class: NETWORK

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: Meshalkin Research Institute of Pathology of Circulation (`cardio:org-meshalkin-research-institute-of-pathology-of-circulation`)

## Provenance

Content hash: 3da229471dc74fecdf04c977fbbf35e02bb6afe6c67483fba3ab6a21cd4eb73f
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
